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Natural product biosynthetic pathways generate molecules of
enormous structural complexity and exquisitely tuned biological
activities. Studies of natural products have led to the discovery of
many pharmaceutical agents, particularly antibiotics. Attempts to
harness the catalytic prowess of biosynthetic enzyme systems, for
both compound discovery and engineering, have been limited by
a poor understanding of the evolution of the underlying gene
clusters. We developed an approach to study the evolution of bio-
synthetic genes on a cluster-wide scale, integrating pairwise gene
coevolution information with large-scale phylogenetic analysis. We
used this method to infer the evolution of type II polyketide gene
clusters, tracing the path of evolution from the single ancestor to
those gene clusters surviving today. We identified 10 key gene types
in these clusters, most of which were swapped in from existing
cellular processes and subsequently specialized. The ancestral type
II polyketide gene cluster likely comprised a core set of five genes,
a roster that expanded and contracted throughout evolution. A key
C24 ancestor diversified into major classes of longer and shorter
chain length systems, from which a C20 ancestor gave rise to the
majority of characterized type II polyketide antibiotics. Our findings
reveal that (i) type II polyketide structure is predictable from its gene
roster, (ii) only certain gene combinations are compatible, and
(iii) gene swaps were likely a key to evolution of chemical di-
versity. The lessons learned about how natural selection drives
polyketide chemical innovation can be applied to the rational
design and guided discovery of chemicals with desired structures
and properties.
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Microorganisms produce structurally diverse secondary metab-olites, many of which have been successfully repurposed by
mankind as pharmaceutical agents. These molecules are manu-
factured by multienzyme assemblies, many of which are encoded
by biosynthetic gene clusters. Elucidating the history of how gene
clusters evolved to produce a powerhouse of structurally diverse
and biologically active molecules could reveal how synthases can
be engineered to produce new therapeutic agents. Phylogenetic
analyses have revealed evolutionary histories of individual bio-
synthetic genes, but the mechanisms of evolution of entire gene
clusters are not well understood (1–4).
Here, we present an approach to study gene cluster evolution
on a cluster-wide scale, and we apply it to type II polyketide gene
clusters. In their native bacterial hosts, type II polyketides are
thought to confer a selective advantage by serving important
roles in chemical defense, signaling, and virulence (5). This class
is rich in pharmacologically relevant compounds, including po-
tent antibiotics (e.g., tetracycline) and anticancer agents (e.g.,
doxorubicin) (5, 6). The historical success of type II polyketides
in the clinic, coupled with the need for new antibiotics, has
spurred great interest in identifying and engineering new com-
pounds in this class (7). Type II polyketide gene clusters encode
discrete and dissociable polyketide synthase (PKS) enzyme as-
semblies. The core proteins of type II PKS gene clusters are a
ketosynthase (KS)-alpha subunit and a KS-beta subunit, also
known as a chain length factor (CLF), which collaborate with the
acyl carrier protein (ACP) to construct a nascent polyketide
chain. Reactive beta-keto chains are converted into structurally
diverse molecules by the action of tailoring enzymes, including
cyclases and reductases, giving rise to the final branching, oxi-
dation state, and cyclization pattern of the polyaromatic product.
The remarkable chemical diversity observed in this class of
molecules is thought to originate from variations in chain length
and tailoring reactions. Previous phylogenetic studies have
revealed the role of the CLF in controlling the chain length of
type II polyketides (8–15), but the evolution of the KS-CLF
within the context of the entire protein assembly is not well
understood.
Our analyses trace the evolution of type II PKS gene clusters,
from the initial divergence of an ancestral KS into the homolo-
gous KS-CLF pair, and the gain of several key classes of acces-
sory enzymes. We identified 544 putative type II PKSs in public
genome databases, ∼15% of which encode a product that has
been structurally characterized. Our studies revealed that the
ancient pairing of the KS and CLF coincided with the gain of two
accessory genes responsible for ring cyclization, an evolutionary
shift that likely resulted in the introduction of the characteristic
polyaromatic structure of type II polyketides. Subsequent gene
swaps of accessory enzymes were highly coordinated with mu-
tations to the KS-CLF, thereby enabling PKSs to diversify the
chain length, oxidation state, and overall shape of their molec-
ular products. These findings provide an unprecedented glimpse
into the mechanisms by which evolution has led to the chemical
diversity of natural products. The application of these methods
to other gene collectives could unveil additional modes of
chemical diversity generation in nature.
Significance
Type II polyketide natural products are powerful antimicrobial
agents that are biosynthesized within bacteria by enzyme-
encoding clusters of genes. We present a method to elucidate
the evolution of these gene clusters as a whole, illuminating
how natural selection has led to the chemical diversity of type
II polyketides. Our approach can be applied to understand how
other natural product gene clusters evolve. This understanding
may aid efforts to access novel natural products and to design
rational enzyme assemblies that produce chemicals of desired
structures and activities.
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Results and Discussion
Evolution of the Core KS and CLF Proteins. The KS, CLF, and ACP
proteins form the minimal assembly required to build a nascent
polyketide chain (SI Appendix, Fig. S1). Ridley et al. (8) pro-
posed that the core KS and CLF genes of type II PKS gene
clusters arose from an ancient KS duplication. Using a large set
of recent bacterial genomic sequence data, we performed large-
scale phylogenetic analysis of many newly sequenced homologs
of the KS and CLF genes (SI Appendix, Fig. S2), resulting in two
new insights into the nature and timing of this duplication in the
context of bacterial evolution. First, type II PKS KSs appear
more similar to primary metabolic FabF KS homologs from the
fatty acid (FAS) pathway than to the KS of several secondary
metabolic type II PKS relatives, such as aurachin and kedarcidin
(1, 3, 4, 16–18). These other secondary metabolic gene clusters
harbor tandem KSs that appear superficially similar to the tan-
dem KSs of type II PKS gene clusters (SI Appendix, Fig. S2 A and
B). However, our detailed phylogeny reveals that the tandem KS
pair of these other secondary metabolic gene clusters arose from
a separate duplication event, distinct from the duplication
leading to canonical type II PKS KS-CLF genes. Second, despite
type II PKS clusters having been identified exclusively in Acti-
nobacteria, and despite their high similarity to FabF homologs
(SI Appendix, Fig. S2 A and B), the KS and CLF proteins do not
clade with actinobacterial FabF (SI Appendix, Fig. S2C). The
divergence of the type II KS from the FabF KSs predates major
bacterial speciation events, as visible by the FabF sequences
grouping by phylum of origin. This finding suggests that type II KS
and CLF genes did not evolve from an ancestral actinobacterial
FabF, but rather diverged from the FabF common ancestor well
before the actinobacterial phylum had formed.
To study the evolution of all type II PKS gene clusters sequenced to
date, we searched public genomic sequence data in the GenBank
(February 19, 2015) for KS-CLF gene homologs present in tandem
(SI Appendix,Methods and Figs. S3–S5). We defined a redundancy
threshold of 87%CLF sequence identity (at which gene clusters tend
to encode identical rather than unique small molecules; SI Appendix,
Methods). Our search identified 544 nonredundant putative type II
PKS gene clusters, exclusively in bacteria (Fig. 1). These gene clus-
ters included 78 (all actinobacterial) whose secondary metabolite
products have been structurally characterized. We identified many
orphan gene clusters in nonactinobacterial species; these gene clus-
ters are very anciently diverged from actinobacterial homologs (not
likely recently horizontally transferred), with sparse coverage of se-
quence space (Fig. 1 and SI Appendix, Fig. S2). The nonactinobacterial
gene clusters are attractive targets for bioprospecting, because
their origin in phyla such as Firmicutes and Proteobacteria
could allow for expression in tractable nonactinobacterial
heterologous hosts.
Phylogenetic analysis of characterized genes corroborated
previous findings that CLF proteins group by chain length, in
both the large dataset of 544 putative type II PKS clusters (Fig.
1) and the smaller set of 78 characterized gene clusters (Fig. 2).
We computationally tested the long-standing hypothesis that the
volume of the KS-CLF amphipathic cavity, which houses the
growing polyketide chain during biosynthesis, is a main de-
terminant of polyketide chain length (5, 8–15). Using the solved
actinorhodin KS-CLF structure as a template for in silico mu-
tagenesis, we calculated the predicted volume of the KS-CLF
cavity for five PKS clades (Fig. 2): C16–C18, C20, C24, C26, and
C28–C30 (SI Appendix, Fig. S6 and Table S1). Larger KS-CLF
cavities are correlated with longer polyketides (SI Appendix,
Table S2). Interestingly, the predicted change in cavity volume
is more pronounced between C16–C24 (347 A3) than C24–C30
(81 A3). This observation could reflect the limitation of relying
on homology models built from a single, short-chain template
structure, or it may suggest that the cavity size of the KS-CLFs
encoding the largest polyketides does not expand enough to
accommodate the entire nascent polyketide chain. It is possible
that in the case of the longest polyketides (C28–C30), auxiliary
enzyme(s) create an expanded solvent-excluded cage, which serves
to protect reactive polyketide intermediates (5, 6, 12). Our cluster-
wide analysis reveals that CLF mutations are correlated with
changes to the gene roster (discussed below).
Evolution of Type II PKS Accessory Enzymes. The origin and di-
versification of type II PKS enzymes outside of the KS and CLF
are not well understood. To study cluster-wide evolution, we first
identified classes of accessory genes frequently clustered within
30 kb of the KS-CLF gene pair (Fig. 2, Table 1, and SI Appendix,
Fig. S4). We developed a method to detect gene swap events,
building upon existing approaches (19, 20) to quantify gene pair
coevolution by comparing protein similarity scores between pairs
of homologs. Correlated similarity scores suggest that gene types
coevolved (Fig. 3 A and B). Our results confirmed that the core
KS and CLF coevolved with little to no gene swaps: when two
KSs from different genomes have high similarity, the neighboring
CLFs also have high similarity, and when the KSs have low simi-
larity, the neighboring CLFs also have low similarity (Fig. 3C and
SI Appendix, Fig. S7A). We applied this framework to detect
coevolution of tailoring genes with the core KS, and extended it
to detect discrete homologous gene swap events as off-diagonal
groups (Fig. 3B).
Polyketide backbone. The nascent polyketide chain is constructed
through the collaboration of the KS-CLF with the ACP (SI
Appendix, Fig. S1). All characterized gene clusters for which
there is sufficient coverage (30 kb flanking the KS-CLF) contain
an ACP (Table 1). Large-scale phylogenetic analysis of diverse
ACP homologs revealed that type II PKS ACPs form a clade
distinct from primary FAS and other secondary ACPs (SI
Appendix, Fig. S8). The KS and clustered ACP genes share a
correlated evolutionary history, suggesting they coevolved (Fig.
3D and SI Appendix, Fig. S7 B and C). Interestingly, several
anciently diverged orphan clusters (top of Figs. 1 and 2), do not
harbor an ACP homolog, suggesting that this gene was either
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Fig. 1. Phylogeny of CLF protein sequences from 544 putative type II PKS gene
clusters. Red numbers represent key ancestors. Leaf colors represent phylum of
origin. Gene clusters clade by polyketide chain length (noted on the right).
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absent from the initial ancestor or lost from multiple extant
clusters. The ACP-less clusters must use either an alternative
mechanism of biosynthesis or an ACP encoded outside the
gene cluster.
Besides the ACP, other genes involved in backbone bio-
synthesis include acyltransferase (AT) and priming KS (KSIII).
Most characterized type II systems are primed with acetyl units
and “borrow” these enzymes from the FAS pathway (8–15, 21–
23). Systems using nonacetate starting units rely on secondary
AT and KSIII enzymes (Fig. 2, Table 1, and SI Appendix, Fig. S1)
and produce polyketides with longer alkyl and alkenyl substitu-
ents. We found KSIIIs clustered primarily with long-chain (C28–
C30) systems and ATs clustered with C21 systems (Fig. 2), and
both underwent gene swaps (SI Appendix, Fig. S9).
Oxidation state of the polyketide.Ketoreductase (KR) domains have
a profound effect on the final product, because the oxidation state
of the nascent polyketide chain can direct the regiochemistry of
subsequent cyclizations (6). We found that most gene clusters
contain at least one KR gene (Table 1). Previous phylogenetic
analysis suggested there are four main classes of type II PKS KRs,
which correlate with the regiospecificity of the reduction event: C9,
C15, C17, and C19 (24). The four main classes of KRs are distinct
at the sequence level, evolved with their clustered KS (SI Appendix,
Figs. S9 and S10), and underwent clear swapping events (Fig. 3E).
Cyclization of the polyketide. Cyclases function in a chaperone-like
manner to direct regio- and stereoselective intramolecular
cyclization of the polyketide chain (6, 25, 26). We identified four
commonly occurring, nonhomologous categories of cyclases in
type II PKS gene clusters: TcmN-like, OxyN-like, TcmI-like, and
TcmJ-like (Fig. 3 and Table 1). We found no recognizable se-
quence or structural similarity between the four categories,
suggesting that they evolved from four distinct ancestors. The
striking finding that a TcmN cyclase homolog is present in 94% of
characterized type II PKS gene clusters (Table 1) prompted us to
focus on its role in the origin and evolution of type II PKS gene
clusters. Remarkably, genes encoding TcmN and OxyN cyclase genes
are present in even the most anciently diverged type II PKS clusters,
suggesting that the introduction of these genes into the ancestral gene
cluster coincided in time with the ancestral KS-CLF duplication
(Fig. 2). The TcmN-like cyclase participates in first- and second-ring
CP002780 2228982 (Orphan, Desulfotomaculum ruminis, Firmicute), TcmN, OxyN
E. coli FabF YP_489363.1
NZ_JUEI01000042 15707 (Orphan, Paenibacillus sp., Firmicute), TcmN, OxyN, TcmJ
AXVN01000027 30801 (Orphan, Blautia wexlerae, Firmicute), TcmN, OxyN
CP003646 5374537 (Orphan, Gloeocapsa sp., Cyanobacteria), TcmN, OxyN, TcmJ
X62518 Cur pigment C24 (acetyl), ACP, TcmN, TcmI, TcmJ
X55942 WhiE pigment C24 (acetyl), ACP, TcmN, TcmI, TcmJ
L05390 Sch pigment C24 (acetyl), ACP, TcmN, TcmJ
AY233211 Gilvocarcin V C21 (propionyl), ACP, AT
CP002801 2790235 (Orphan, Frankia symbiont), ACP, TcmN, TcmI, TcmJ
CP000820 Frankiamycin A C24 (acetyl), ACP
AY196994 Hedamycin C24 (hexadienyl), ACP, AT
KF515737 Lomaiviticin C21 (propionyl), ACP(2), AT(2), TcmN(2)
EU147299 Lactonamycin C20 (glycine), ACP(2), TcmN, TcmI, TcmJ
M80674 Tetracenomycin C20 (acetyl), ACP, TcmN, TcmI, TcmJ
AM900040 Elloramycin C20 (acetyl), ACP, TcmN, TcmI, TcmJ
L35560 Daunorubicin C21 (propionyl), AT
DQ280500 Cosmomycin C21 (propionyl), AT
KF563088 Nivetetracyclate A C21 (propionyl), ACP, AT
AF257324 Aclacinomycin A C21 (propionyl), ACP, AT
FJ483966 Polyketomycin C20 (acetyl), ACP, TcmN(2), OxyN
AF254925 Enterocin C21 (benzoyl), ACP, AT
AF293442 R1128 C18 (alkylacyl), ACP(2), KSIII, AT, TcmN, OxyN
EU852062 Alnumycin C18 (butyryl), A
AF058302 Frenolicin C18 (butyryl), ACP(2), KSIII, AT
AB103463 Medermycin C16 (acetyl), ACP
AL939122 Actinorhodin C16 (acetyl), ACP
AJ011500 Granaticin C16 (acetyl), ACP
FJ719113 Erdacin C16 (acetyl), ACP
AF098965 Naphthocyclinone C16 (acetyl), ACP, TcmN(2)
KJ437438 Rishirilide A C19 1 (methylpetanoyl), ACP, AT
AJ578458 Chromomycin C20 (acetyl), ACP, AT, TcmN(2), OxyN
GQ409537 SF2575 C19 (malonamyl), ACP, KSIII(2)
KC870000 Chelocardin C20 (acetyl), ACP
JX262387 Dactylocycline C20 (malonamyl), ACP, AT, TcmN(2), OxyN
DQ143963 Oxytetracycline C20 (malonamyl), ACP, AT
HM627755 Chlortetracycline C19 (malonamyl), ACP
JN038178 Kosinostatin C20 (acetyl), ACP
AJ224512 Nogalamycin C20 (acetyl), ACP
AM156932 Steffimycin C20 (acetyl), ACP
KF040454 Arimetamycin C20 (acetyl), ACP
KJ437437 Mensacarcin C20 (acetyl), ACP
X89899 Mithramycin C20 (acetyl), ACP, TcmN(2), OxyN
HQ828986 X26 C20 (acetyl), ACP
DQ915964 Aranciamycin A C20 (acetyl), ACP
X77865 Griseusin C20 (acetyl), ACP
FN565485 Ravidomycin C21 (propionyl), ACP(2), AT
FN565166 Chrysomycin C20 (acetyl), ACP(2), AT
GU134622 Azicemicin C20 (aziridyl), ACP, AT
AJ786382 Chartreusin C20 (acetyl), ACP
HM193369 Fluostatin C20 (acetyl), ACP
FJ670504 Saquayamycin Z C20 (acetyl), ACP
JX843821 Tetarimycin C20 (acetyl), ACP, TcmN, OxyN
HM055942 BE 7585A C20 (acetyl), ACP
NZ KE354310 Julichrome C18 (acetyl), ACP
NZ AOPZ01000074 Setomimycin C18 (acetyl), ACP
AY034378 Rabelomycin C20 (acetyl), ACP
AF080235 Landomycin C20 (acetyl), ACP
NZ AGSW01000147 Kiamycin C18 (acetyl), ACP
AJ628018 Sch47554 C20 (acetyl), ACP
KC962511 Grincamycin C20 (acetyl), ACP
X87093 Urdamycin C20 (acetyl), ACP
AB524586 Hatomarubigin C20 (acetyl), ACP
AF324838 Simocyclinone C20 (acetyl), ACP(3), A
AY228176 PD 116740 C20 (acetyl), ACP, TcmI
AJ632203 Oviedomycin C20 (acetyl), ACP
KM264312 Chattamycin A C20 (acetyl), ACP
AF126429 Jadomycin C20 (acetyl), ACP
AY228175 Kinamycin C20 (acetyl), ACP
FJ915123 TLN 05220 C28 (butyryl), ACP, AT
AB469194 FD 594 C28 (butyryl), ACP(2), KSIII, AT
AM501485 Benastatin C28 (hexanoyl), ACP
AF525490 Fredericamycin C30 (hexadienyl), ACP, KSIII, AT
GU937384 A 74528 C30 (hexadienyl), ACP, KSIII, AT
AZXI01000002 Arenimycin B C24 (acetyl), ACP
HQ828985 Fasamycin A C26 (acetyl), ACP, TcmN(2), TcmI, TcmJ
KM881706 Calixanthomycin A C26 (acetyl), ACP
EF151801 Pradimicin C24 (acetyl), ACP
KF931341 Arixanthomycin C26 (acetyl), ACP
AF293355 Rubromycin C26 (acetyl), ACP
AF509565 Griseorhodin C26 (acetyl), ACP
GQ421798 Xantholipin C26 (acetyl), ACP
AM492533 Lysolipin C25 malonamyl or (acetyl), ACP
NZ_ADVG01000004 139154 (Orphan, Ktedonobacter racemifer, Chloroflexi), TcmN
AJ585192 Resistomycin C20 (acetyl), ACP, AT, TcmN, OxyN, TcmJ
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cyclizations (27–29), whereas TcmI-, OxyN-, and TcmJ-like cyclases
are thought to direct subsequent ring closures (5, 30). All four of
these categories share an evolutionary history with their clustered KS
(Fig. 3 F–I), and the TcmN and OxyN genes display evidence of
homologous gene swapping (Fig. 3 F and G).
Inferring the Ancestral Type II PKS Gene Cluster.We found that gene
cluster architecture is remarkably predictable based only on CLF
protein sequence, with accessory gene architectures consistent
within each CLF clade (Fig. 2). This finding suggests that CLF
sequence mutations are correlated with the presence or absence
of surrounding genes, and there have been a finite number of
major evolutionary events, each represented by a different CLF
clade. Each clade in the phylogeny represents a discrete evolu-
tionary “solution” developed by the clade’s single ancestor, and
the architecture of each ancestor is generally revealed by the
shared makeup of its descendants. Fig. 4 summarizes the observed
evolution of these key ancestors (represented as red numbers in
Figs. 1, 2, and 4), in terms of both their encoded chain length and
gene cluster architectures (accessory enzymes).
To elucidate the architecture of the ancestral type II PKS gene
cluster existing immediately after the KS-CLF pairing (ancestor
1 in Figs. 1, 2, and 4), we studied the most anciently diverged
clusters that descended directly from this single ancestor (Fig. 4
and SI Appendix, Fig. S11). These gene clusters are orphans
encoding unknown molecules, but their cluster architectures are
available from our analysis and exhibit remarkable conservation
in gene makeup: Nearly all harbor a KS, CLF, TcmN cyclase,
and OxyN cyclase, and many harbor an ACP, suggesting that the
ancestor of all PKS gene clusters (ancestor 1) harbored these five
genes. It is possible that some of these genes were clustered with
the KS before the KS-CLF pairing. To investigate this possibility,
we performed a detailed analysis of the origin of the tandem KS-
CLF. These two genes are homologous, and previous suggestions
that they arose from a gene duplication implies that this duplication
occurred in a single species, at a single genetic locus (8). However,
an alternative hypothesis, that the ancestral KS diverged by evolu-
tion in two different species followed by a later reunion of the two
genes in a single species, cannot be ruled out from the existing
sequence data. We identified a clade of gene clusters comprising a
single KS clustered with an ACP and TcmN homolog, which could
represent either (i) descendants of an ancestral cluster before a
“swapping in” of the CLF or (ii) descendants of an ancestor that
harbored the KS, CLF, ACP, and TcmN but subsequently lost the
CLF. Very few gene clusters have been sequenced that descended
from these key intermediate ancestors, unfortunately obscuring the
order of events in which these five key genes became clustered.
Additional sequencing data will better elucidate these early evo-
lutionary paths.
The apparent ancientness of the TcmN and OxyN cyclase genes
prompted us to investigate their evolutionary origins. It has been
shown that the 3D structure of TcmN cyclase bears similarity to the
“hot dog” fold of dehydratase proteins, which are often clustered
with PKS/FAS systems (27). Our own homology searches found
that OxyN-like cyclases share similarity and active site motifs with
formamidases and metal-dependent hydrolases (31). Both of these
protein classes are ancient, with homologs performing diverse
functions in diverse species. The type II PKS homologs comprise
only a small, recently evolved subset of each class (SI Appendix,
Figs. S12 and S13), suggesting that these cyclases were swapped
into the gene clusters from other systems and subsequently evolved
PKS-specific functions.
Functional Consequences of Gene Swaps in Type II PKS Gene Clusters.
Having established the likely architecture of the ancestral type II
PKS gene cluster as KS, CLF, ACP, and TcmN and OxyN cyclases,
we traced the evolution of this ancestral cluster into characterized
extant clusters surviving today. We inferred key ancestors from
Fig. 2 and deduced functional consequences of the observed gene
swaps; the results are summarized in Fig. 4.
Resistomycin represents an important type II polyketide, because
its cluster is the most anciently diverged of the characterized set of
78. We studied all sequenced homologs of resistomycin to infer the
common ancestor (ancestor 2) of all 78 characterized systems (Fig.
4 and SI Appendix, Fig. S11). Few systems related to resistomycin
have been sequenced; many of the nearest relatives are from
metagenomic sequencing projects, including uncultivable bacteria.
Of the sequences that are available, the resistomycin-like architec-
ture of KS-CLF, ACP, TcmN, OxyN, and TcmJ is conserved, sug-
gesting that ancestor 2 gained a TcmJ cyclase. Interestingly, some
distant relatives of resistomycin harbor no ACP gene but retain the
three cyclases. Such anciently diverged gene clusters may represent
interesting targets for bioprospecting, given their unique sequence
and nonactinomycete origin.
The next key ancestor, which gave rise to the spore pigments and
all other systems (ancestor 3), underwent a swap of TcmI with
Fig. 3. Coevolution of type II PKS KS with partner genes. (A) Schematic illus-
trating two nucleotide records and the clustered (within 30 kb) KS + partner on
each record. (B) KS1-KS2 pairwise amino acid identities are plotted vs. pairwise
identities of a clustered partner. (C–I) Correlation of evolutionary histories of
the KS with partner genes.
Table 1. Number of gene clusters having at least one of the
listed accessory genes clustered within 30 kb of KS-CLF genes
Gene
Percentage of reference
set (78 clusters), %
Percentage of 544
putative clusters, %
KS 100 100
CLF 100 100
ACP 97 77
Acyltransferase 29 15
KSIII 12 7
C9 KR 55 36
C15 KR 14 8
C17 KR 8 3
C19 KR 18 8
TcmN cyclase 94 77
TcmI cyclase 55 46
TcmJ cyclase 28 32
OxyN cyclase 21 13
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OxyN (Figs. 2 and 4), both of which are thought to catalyze late ring
cyclization events. The TcmI and OxyN cyclase genes are observed
together in none of the 544 putative clusters (SI Appendix, Fig. S14),
so these genes may be mutually exclusive. Interestingly, OxyN re-
appears in one of the C20 subclades (Fig. 2), corresponding to a loss
in TcmI (ancestors 7 and 8). This gene swap appears correlated with
changes to polyketide ring topologies, because those C20 PKSs that
use OxyN produce molecules with linear topology, whereas those
C20 PKSs that use TcmI display a kink in the polyaromatic back-
bone (Fig. 4 and SI Appendix, Table S3).
Further diversification of type II PKS gene clusters occurred
upon the introduction of KR genes (Fig. 4). We observe that the
C19 KR was introduced into the ancestor of frankiamycin (32)
and all other characterized clusters (ancestor 4).
One of the most striking findings of the cluster-wide phylo-
genetic analysis is that all C16- to C21-encoding gene clusters
arose from a single common ancestor (ancestor 7). This ancestor
was likely C20, because there are nonmonophyletic clades of C20
systems descending from it (Fig. 2). This C20 ancestor pro-
liferated rapidly and gave rise to the majority of characterized
type II polyketide antibiotics known today (e.g., tetracyclines)
(Figs. 1, 2, and 4). Ancestor 7 underwent a major, coordinated set
of mutations and gene swaps. We established above that the cavity
volume of these systems is significantly smaller than the cavity
volume of the C24–C30 systems (SI Appendix, Table S2). The gene
architectures are also significantly different. The more anciently
diverged, longer-chain systems harbor a monomeric TcmN gene,
whereas the more recently diverged CLFs encoding shorter chain
lengths (C16–C21) harbor a dimeric form of the gene (e.g., oxy-
tetracycline otcD1). We hypothesized that the ancestral TcmN
monomer had duplicated to become the OtcD1-like dimer, but,
surprisingly, phylogenetic analysis of TcmN homologs refuted this
hypothesis; rather, the dimer and the monomer diverged before type
II PKSs proliferated in Actinobacteria, and the sequence-divergent
dimeric homolog (OtcD1-like) was swapped into the C16–C21
common ancestor (ancestor 7), replacing the monomeric TcmN-like
form (Figs. 3F and 4 and SI Appendix, Fig. S12).
An additional major change in key ancestor 7 was the replace-
ment of a C19 KR with a C9 KR. Extensive biochemical analysis
and docking studies suggest that KR interactions with the minimal
PKS are essential during biosynthesis (33, 34), which could explain
why most clusters harbor either a C9 or C19 KR (although there are
exceptions, such as resistomycin, the spore pigments, and anciently
diverged orphans that harbor no KR). The C19- to C9-KR gene
swap events can be seen at the bottom of Fig. 3E, where KSs
of high sequence identity are clustered with KRs with low se-
quence identity. Finally, ancestor 7 lost a TcmJ homolog. Taken
together, these cluster-wide observations suggest that the transi-
tion from ancestor 6 to ancestor 7 involved the coordinated swaps
of cyclases (TcmN monomer with TcmN dimer and loss of TcmJ)
and KRs (C19 with C9). This ancestor further diversified via the
introduction of additional KRs (C15 and C17) and cyclase gene
swaps (TcmI to OxyN) to yield the diverse extant clusters seen
today (Figs. 2 and 4).
The functional consequences of key evolutionary events (Fig. 4)
can be predicted based on the known biochemistries of PKS
enzymes (SI Appendix, Fig. S1). The product of the original,
ancestral type II PKS gene cluster (ancestor 1 on Fig. 4) was
likely an acetyl-primed C20–C24 polyketide cyclized at the C9–
C14 position, because TcmN-like cyclases almost always fa-
cilitate C9–C14 cyclization events in the absence of a C9 KR
(95% of pathways; SI Appendix, Table S4). The introduction of
Fig. 4. Evolution of type II PKS gene clusters by coordinated gene swaps. The tree traces the key ancestors from the most anciently diverged type II PKS gene
clusters (Top) to the more recently diverged C20 systems, such as oxytetracycline and landomycin (Bottom). Highlighted in red are key ancestors, whose gene cluster
architecture is inferred on the left. Representative polyketide structures from each clade are shown, and activity sites for KR (gold), TcmN cyclase (green), and KSIII (light
blue) are shown on the chemical structures.
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the C19 KR in ancestor 4 likely changed the oxidation state of
the polyaromatic core. The gene swap of C9 for C19 likely
changed both the oxidation state and the cyclization pattern,
because in the presence of a C9 KR, the TcmN-like cyclase cata-
lyzes C7–C12 ring closure (5, 10, 25, 35). The swap of TcmI for
OxyN in ancestor 8 is correlated with a change in the polyketide
structure from bent to linear. The global chemical innovation
was likely driven by a combination of these key gene swap events
with mutations to the KS-CLF core.
Conclusions
Type II PKSs are responsible for the biosynthesis of pharmaco-
logically relevant natural products, and discovery and engineering of
new polyketides are of great interest. Investigating the evolution of
entire microbial gene clusters, as opposed to individual genes, is a
nascent field that has become possible only recently with the large
number of microbial genomes being sequenced. We tackled the
question of how type II PKS gene clusters evolved by studying the
evolution of the KS-CLF and its coevolution with accessory genes.
Remarkably, divergence of the PKS KS (and CLF) from the FabF
KS apparently occurred before bacterial speciation. Chemical in-
novation was driven by mutations in the KS-CLF gene pair to ac-
commodate polyketides of variable length and changes to the
accessory gene roster to diversify the oxidation state, priming unit,
and cyclization patterns of the natural product.
The methods presented here for studying the evolution of type II
PKSs are generalizable and can be applied to other biosynthetic
systems, where gene swaps may also be a source of chemical di-
versity. In addition to reconstructing the evolutionary history of an
important class of natural products, these results represent a
launching point for bioprospecting in three ways. First, the lessons
learned about nature’s strategies to generate chemical diversity may
guide rational design and engineering of hybrid synthases (36). Our
study reveals patterns in gene compatibility that can be used as
ground rules for engineering. Second, we identified orphan gene
clusters from diverse phyla that may encode novel chemical struc-
tures that could potentially be expressed in tractable nonactinobac-
terial hosts (18, 37, 38). Finally, ancestral sequence reconstruction,
which has been applied to single proteins and whole genomes (39,
40), could be applied to ancestral gene clusters, leading to a po-
tentially novel source of chemical diversity: the resurrection of ex-
tinct gene clusters and chemicals.
Methods
Materials and methods, along with supporting figures and a complete ref-
erence set of the 78 characterized type II polyketides, are provided in SI
Appendix.
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